Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

NCT01607450 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Healthy

Interventions

DRUG: GLP-1 Low Dose
DRUG: GLP-1 Mid-Range Dose
DRUG: GLP-1 High Dose
DRUG: Saline

Sponsor

Indiana University

Collaborators

[object Object]